Navigation Links
STERIS Corporation Announces Fiscal 2008 Third Quarter Results
Date:1/30/2008

hnologies, products or applications, or the Company's business initiatives will take longer, cost more or produce lower benefits than anticipated, (c) the possibility that application of or compliance with laws, court rulings, regulations, certifications or other requirements or standards may delay or prevent new product introductions, affect the production and marketing of existing products, or otherwise affect Company performance, results, or value, (d) the potential of international unrest or effects of fluctuations in currencies, tax assessments or rates, raw material costs, benefit or retirement plan costs, or other regulatory compliance costs, (e) the possibility of reduced demand, or reductions in the rate of growth in demand, for the Company's products and services, and (f) the possibility that anticipated cost savings may not be achieved, or that transition, labor, competition, timing, execution, regulatory, governmental, executive transition or other issues or risks associated with the matters described in this release, or the referenced conference call, may adversely impact Company performance, results, or value.

STERIS Corporation

Consolidated Condensed Statements of Income

(In thousands, except per share data)

Three Months Ended Nine Months Ended

December 31, December 31,

2007 2006 2007 2006

(Unaudited)(Unaudited)(Unaudited)(Unaudited)

Revenues $313,974 $298,967 $889,920 $847,570

Cost of revenues 183,775 171,266 517,339 487,733

Gross profit 130,199 127,701 372,581 359,837

Operating expenses:

Selling, general, and

administrative 85,612 82,594 260,100 243,789

Restructuring expense
'/>"/>

SOURCE STERIS Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
2. STERIS Corporation Announces Date of Fiscal 2008 Second Quarter Earnings Release and Conference Call
3. STERIS Corporation Announces Fiscal 2008 Second Quarter Results
4. STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call
5. STERIS Corporation Declares Regular Quarterly Dividend
6. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
7. Brooke Franchise Corporation Announces Selected July Results
8. MedThink Communications Retained by NanoBio Corporation
9. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
10. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
11. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)... Mo. There is no cure for spinal muscular atrophy...ng of muscles and is the leading genetic cause of ...rs have discovered a new therapeutic target that i...d by SMA. The new therapy enhanced muscle strength...fespan in a SMA model. , "This therapy does no...
(Date:1/7/2009)...Illinois and Jerusalem, Israel, January 7, 2009 --... - Teva Joint Venture (JV) announced today that Ch...cer centers in Europe, the United States and Israe...y. The pivotal registration study is testing the s...ive transplantation option for adolescents and adu...
(Date:1/7/2009)...PLAINS, N.J., Jan. 7 Im...utical company focused on developing monoclonal an...s, today announced that Cynthia L. Sullivan, Presi...ng at the 27th Annual J.P. Morgan Healthcare Confe...Sullivan,s presentation, which is scheduled for Th...
(Date:1/7/2009)..., Free fully customizable diet plan offered by Dr....- Timothy S. Harlan, M.D., also known as Dr. Gourm... customizable diet and menu planning software , w...user/login.php The name of the plan reflects Dr. ...ealthy, delicious foods - are the key to eating he...
Breaking Medicine News(10 mins):Health News:Researchers discover target that could ease spinal muscular atrophy symptoms 2Health News:Children's Memorial Hospital, Chicago, joins ExCell study 2Health News:Immunomedics to Present at 27th Annual J.P. Morgan Healthcare Conference 2Health News:Immunomedics to Present at 27th Annual J.P. Morgan Healthcare Conference 3Health News:Dr. Gourmet Launches The Quality Calorie Diet Plan - Free Online Meal Planning Software 2Health News:Dr. Gourmet Launches The Quality Calorie Diet Plan - Free Online Meal Planning Software 3
...l is the hardest tissue produced by the body. It c... layer of cells that is lost by the time the tooth...nder of its lifetime vulnerable to wear, damage, a...xciting to consider the prospect of artificially g...
...al and motivational video, designed to increase em...low vision patients increased knowledge but did no...While our video clearly succeeded in increasing pa...ion and the availability of adaptive devices and t...
...tial chemotherapy treatment, radiation may be a be...IIA non-small-cell lung cancer, //according to a r...l of the National Cancer Institute. The authors su...py and radiation should be the preferred treatment...
...uctal adenocarcinoma is an almost uniformly fatal ...is. However, a small percentage //of patients deve...h cystic lesions that can be detected earlier, is ...rvival rate. Why cystic ductal pancreatic cancer b...
Other Medicine News:Health News:Scientists Re-grow Dental Enamel from Cultured Cells 2Health News:Educational Video Increases Knowledge but Not Behavior 2Health News:Educational Video Increases Knowledge but Not Behavior 3Health News:Radiation Preferred Over Surgery for Patients With Some Stages of Lung Cancer 2Health News:Genetic Pathways to Curable and Incurable Forms of Pancreatic Cancer Identified 2Health News:Genetic Pathways to Curable and Incurable Forms of Pancreatic Cancer Identified 3
(Date:12/17/2008)...r the first time that normal stem cells can act as... , MEMPHIS, Tenn., Dec. 17 /PRNewswire-USNewsw...ch Hospital have answered a central question in ca...ise to tumors. Stem cells are immature cells that ...rentiated cells that compose the range of body tis...
(Date:12/17/2008)...ire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: ...R. Contag, Ph.D., to Delcath,s Board of Directors....extensive experience working with international an.../www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO...ies, Inc. in 2006 and served as CEO. Prior to sta...
(Date:12/16/2008)...Between Inflammation & Alzheimer,s Disease , ...e Roskamp Institute today announced that its resea...ion and Alzheimer,s disease and have identified a ... for intervention in this disease. The study, led...detailed in the American Chemical Society,s Chemi...
(Date:12/15/2008)...18, 2008 at 9 a.m. Eastern Time , , VALENC...nnKind Corporation (Nasdaq: MNKD ) will host a ... final two Phase 3 studies of AFRESA(TM), the comp... at 9 a.m. Eastern Time on Thursday, December 18, ... by telephone, please dial (888) 677-5721 or (210)...
Breaking Medicine Technology:Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 3Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 2Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 3Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 3MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 2Rigel Announces Pricing of Public Offering of Common Stock 2924 1Rigel Announces Pricing of Public Offering of Common Stock 2924 2Lose Weight Gain Life 3A New Website to Help People Seeking Information on Obesity Surgery 10704 1Lose Weight Gain Life 3A New Website to Help People Seeking Information on Obesity Surgery 10704 2Lose Weight Gain Life 3A New Website to Help People Seeking Information on Obesity Surgery 10704 3FDA Warns Epilepsy Drugs May Raise Suicide Risk 10700 1FDA Warns Epilepsy Drugs May Raise Suicide Risk 10700 2FDA Warns Epilepsy Drugs May Raise Suicide Risk 10700 3Changes needed in how federal government evaluates efficiency of research at EPA other agencies 10695 1Changes needed in how federal government evaluates efficiency of research at EPA other agencies 10695 2
...tchison Whampoa backed pharmaceutical and,healthca... Phase II,proof-of-concept study for HMPL-004 in m...ammatory bowel disease. The trial met,its objecti...an,equivalent drop in clinical symptom score to th...ine standard of care in,mild-to-moderate Ulcerativ...
...e du Myelome (IFM),Trial Presented During IMW -, C...ll/ --,Millennium Pharmaceuticals, Inc. today repo...ve Phase III clinical trial evaluating a,VELCADE b...MM),patients. As induction therapy prior to stem c...py produced a high complete remission,/ complete r...
Other Medicine Technology:Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6
Form should always follow function. Thats why EagleVision created the FlexPlug, the only tapered shaft punctum plug with contouring traction ribs. Designed to provide the ultimate in flexibility, fix
...n Prevail's steerable tip, along with various fixe... the curve you need, when you need it. Inject cont...ac venous anatomy, adjust course as needed with ti...h by telescoping the Attain Prevail through a stra...
Attain CS Leads. Navigate minimally angled veins with no tortuosity.
The Hancock® II bioprosthesis from Medtronic has more than 15 years of proven clinical experience. Worldwide clinical studies demonstrate that the freedom from structural valve deterioration with
Medicine Products: